OQROGet OQRO Pro
Insider trade

Puma Biotechnology (PBYI)CFO sold ~$27K

Maximo F Nougues, CFO at Puma Biotechnology, sold ~$27K of Puma Biotechnology shares.

~$27K
Approx. value · 4,540 sh @ $5.84
200K
Holds after · shares reported
Traded
Jan 6, 2026
Filed
Jan 9, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 11, 2025InsiderDirector sold ~$97K of PBYI shares in the open market
  2. Jan 6, 2026 · this disclosureInsiderCFO sold ~$27K of PBYI shares in the open market

What came next

  1. Jan 6, 2026Insider · 2 peopleInsiders: 2 sales (~$122K)
  2. Jan 7, 2026Insider · 3 peopleInsiders: 3 sales (~$173K)
  3. Feb 26, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Puma Biotechnology

For Puma Biotechnology, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PBYI page.

Other recent filings by Maximo F Nougues, Chief Financial Officer

The full history of Maximo F Nougues, Chief Financial Officer is on the profile page.

How this filing works

Other disclosures at Puma Biotechnology

Everything OQRO holds on this company is on its PBYI page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data